
|Articles|April 15, 2008
The American Journal of Managed Care
- April 2008
- Volume 14
- Issue 4
Strand V, Singh JA. (Am J Manag Care. 2007;13[suppl 9]:S237-S251)
Advertisement
After the publication of our December 2007 supplement, “Health-related Quality of Life in Rheumatoid Arthritis,” the Editors learned that several authors were not given the opportunity to review the final proofs of their manuscripts. As a result, errors were subsequently identified. Due to the extent of the errors in the article by Strand et al, “Improved Health-related Quality of Life With Effective Disease-modifying Antirheumatic Drugs: Evidence From Randomized Controlled Trials,” we have printed the corrected article in our April issue.
to see a corrected version of this article.
Articles in this issue
over 18 years ago
Furst DE, Khanna D. (Am J Manag Care. 2007;13[suppl 9]:S216-S217.over 18 years ago
Strand V, Singh JA. (Am J Manag Care. 2007;[suppl 9]:S237-S251.over 18 years ago
Furst, DE; Khanna, D. (Am J Manag Care. 2007;13[suppl 9]:S216-S217)over 18 years ago
Association of Insurance Coverage With Chlamydia ScreeningAdvertisement
Related to this article

CMS is adding value-based care (VBC) risk faster than many providers can build the data and tech capacity they need to succeed.

This week in health equity and access: PMOS diagnosis, HIV lung cancer screening, transplant access, atopic dermatitis care, and value-based oncology.

Phase 3 wins for ianalumab and dazodalibep bring targeted therapies closer for Sjögren disease as patients face diagnostic delays and high costs.

Patch testing in Malaysia finds contact dermatitis drivers in chronic hand eczema—nickel and fragrance allergy lead, while cosmetics raise polysensitization risk.

The article explores the use of dose-intensive IV iron replacement to achieve long-term hemoglobin stability in patients with moderate to severe HHT-related bleeding. The approach recognizes what the author calls "the relentless and recurrent nature of HHT-associated bleeding," and may help patients achieve better quality of life.

Although PMOS Awareness Month has ended, the conversation continues, with experts saying closing diagnostic and care gaps requires ongoing efforts.
Advertisement
Advertisement
Trending on AJMC
1
Lung Cancer Screening Lags for People With HIV as Eligibility Triples
2
CMS Finalizes Mandatory GLOBE Model to Test Lower Part B Drug Costs
3
Dual Agonist Survodutide Delivers Up to 13.1% Weight Loss in T2D
4
VYD2311 Shows Superior Safety vs mRNA COVID-19 Vaccine
5



